About Hiran Orgochem
Hiran Orgochem is a company based in Mumbai (India) founded in 1992. It operates as a B2B. Hiran Orgochem operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- Website hiranorgochem.com
- Legal Name Hiran Orgochem Limited
- Date of Incorporation 22 Mar, 1983
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1.30 Cr
FY 2015 · -63% YoY
- Net Loss-₹27.76 Cr
FY 2015 · -2127% margin
- EBITDA-₹28.58 Cr
FY 2015 · -2190% margin
Associated legal entities of Hiran Orgochem
Hiran Orgochem operates through Hiran Orgochem Limited, a listed company (under liquidation). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2015) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hiran Orgochem Limited Listed CIN L51900MH1983PLC029596 | Under Liquidation | 22 Mar 1983 | Mumbai, Maharashtra | ₹1.3 Cr | – | 3 | View details |
Board of directors of Hiran Orgochem Limited (Hiran Orgochem)
Hiran Orgochem Limited is the primary company behind Hiran Orgochem. The board of Hiran Orgochem Limited currently have 3 directors; the longest-serving is Kantilal Mangalchand Hiran, appointed in 1991. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kantilal Mangalchand Hiran DIN 00186885 | Managing Director | 15 Nov 1991 | 34 yrs 10 mo | Hiran Orgochem Limited |
| Hirachand Nemichand Bafna DIN 00187179 | Director | 01 Jun 1992 | 34 yrs 4 mo | Hiran Orgochem Limited |
| Dariyadevi Kantilal Hiran DIN 00187107 | Additional Director | 31 Jan 2015 | 11 yrs 8 mo | Hiran Orgochem Limited |
Financials of Hiran Orgochem
Figures of Hiran Orgochem Limited, the primary company behind Hiran Orgochem, for FY 2015. Revenue was ₹1.30 Cr (-63% year on year). Net loss was -₹27.76 Cr (-2127% margin). EBITDA was -₹28.58 Cr (-2190% margin). Revenue has grown at a compounded annual rate of -70% over three years.
- ₹1.30 CrRevenue · FY 2015 · -63% YoY
- -₹27.76 CrNet loss · -2127% margin
- -₹28.58 CrEBITDA · -2190% margin
- ₹98.66 CrPaid-up capital
- -70%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Hiran Orgochem Limited are on its company page.
Detailed financial statements for Hiran Orgochem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Hiran Orgochem
Hiran Orgochem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Hiran Orgochem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hiran Orgochem
Websites that share an audience with Hiran Orgochem (hiranorgochem.com).
Websites whose visitors overlap most with Hiran Orgochem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| yashpharma.com | 100% | – | – | View details | |
| stridesarco.com | 90% | – | – | View details |
Similar companies to Hiran Orgochem
10 companies that operate in the same segment as Hiran Orgochem (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hiran Orgochem
Hiran Orgochem was founded in 1992.
Hiran Orgochem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Hiran Orgochem, Hiran Orgochem Limited, reported revenue of ₹1.30 Cr for FY 2015, down 63% year on year.
Hiran Orgochem, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and active pharmaceutical ingredients. Manufactures active pharmaceutical ingredients in a competitive market. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Hiran Orgochem's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Hiran Orgochem operates through Hiran Orgochem Limited.
The legal entities of Hiran Orgochem currently have 3 directors, including Dariyadevi Kantilal Hiran, Hirachand Nemichand Bafna, Kantilal Mangalchand Hiran.